Cargando…

Metformin in COVID-19: Is There a Role Beyond Glycemic Control?

CONTEXT: The coronavirus disease 2019 (COVID-19) pandemic is still a cause of worldwide health concern. Diabetes and its associated comorbidities are risk factors for mortality and morbidity in COVID-19. Selecting the right antidiabetic drug to achieve optimal glycemic control might mitigate some of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagendra, Lakshmi, Bhattacharya, Saptarshi, Kalra, Sanjay, Kapoor, Nitin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brieflands 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467582/ https://www.ncbi.nlm.nih.gov/pubmed/37654526 http://dx.doi.org/10.5812/ijem-132965

Ejemplares similares

Early Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications
por: Bhattacharya, Saptarshi, et al.
Publicado: (2021)

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
por: Kalra, Sanjay, et al.
Publicado: (2021)

Barocrinology: The Endocrinology of Obesity from Bench to Bedside
por: Kalra, Sanjay, et al.
Publicado: (2020)

Subclinical Kwashiorkor in Adults: A New Age Paradigm
por: Kapoor, Nitin, et al.
Publicado: (2022)

Diabetes and tuberculosis: a review of the role of optimal glycemic control
por: Niazi, Asfandyar Khan, et al.
Publicado: (2012)

Hepatocrinology
por: Kalra, Sanjay, et al.
Publicado: (2021)

Cardiac Autonomic Neuropathy in Prediabetes: A Case-Control Study
por: Gujjar, Pavan, et al.
Publicado: (2023)

Verapamil improves One-Year C-Peptide Levels in Recent Onset Type-1 Diabetes: A Meta-Analysis
por: Dutta, Deep, et al.
Publicado: (2023)

The AACE 2022 Guideline: An Academic Appraisal
por: Bhattacharya, Saptarshi, et al.
Publicado: (2023)

Metformin in COVID-19: A possible role beyond diabetes
por: Sharma, Swati, et al.
Publicado: (2020)

Glycemic Management after Antenatal Corticosteroid Therapy
por: Kalra, Sanjay, et al.
Publicado: (2014)

Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
por: Hirst, Jennifer A., et al.
Publicado: (2012)

Metformin in the management of diabetes during pregnancy and lactation
por: Priya, Gagan, et al.
Publicado: (2018)

Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
por: Narayanan, Niya, et al.
Publicado: (2022)

Focus on Metformin: Its Role and Safety in Pregnancy and Beyond
por: Newman, Christine, et al.
Publicado: (2023)

Quantifying Remission Probability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2021)

Barophenotypic Characterization – The key to Person Centric Management of Obesity
por: Kalra, Sanjay, et al.
Publicado: (2021)

Glycemic equipoise
por: Kalra, Sanjay, et al.
Publicado: (2017)

Gender Disparities in People Living with Obesity - An Unchartered Territory
por: Kapoor, Nitin, et al.
Publicado: (2021)

A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin?
por: Priya, Gagan, et al.
Publicado: (2017)

Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
por: Kang, Seon Mee, et al.
Publicado: (2021)

Vitamin D, Thyroid Autoimmunity and Cancer: An Interplay of Different Factors
por: Dutta, Deep, et al.
Publicado: (2019)

Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone
por: Davidson, Jaime A.
Publicado: (2013)

Coronavirus disease 2019 and vitamin D
por: Kapoor, Nitin, et al.
Publicado: (2023)

Oral Semaglutide: Dosage in Special Situations
por: Kalra, Sanjay, et al.
Publicado: (2022)

Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012)

Practical and Pragmatic Usage of T3 in Hypothyroidism
por: Kalra, Sanjay, et al.
Publicado: (2023)

Role of Metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Orlistat based Multidrug Therapy in Glycemic Control, Weight Loss, and Euglycemia in Diabesity: A Real-World Experience
por: Dutta, Deep, et al.
Publicado: (2019)

Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes
por: Richard, John W., et al.
Publicado: (2011)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses, Robert G
Publicado: (2010)

Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
por: Du, Guoli, et al.
Publicado: (2020)

Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control
por: Baruah, Manash Pratim, et al.
Publicado: (2019)

Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
por: Youssef, Mahmoud E., et al.
Publicado: (2023)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

Metformin: Midlife maturity, maiden charm
por: Kalra, Sanjay, et al.
Publicado: (2012)

Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach
por: Kalra, Sanjay, et al.
Publicado: (2022)

Improvements in Glycemic Control in Type 2 Diabetes Patients Switched From Sulfonylurea Coadministered With Metformin to Glyburide-Metformin Tablets
por: Duckworth, Wiliam
Publicado: (2003)

Metformin; A character actor in the leptin story!
por: Baruah, Manash P., et al.
Publicado: (2012)

Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports
por: Chawla, Manoj, et al.
Publicado: (2023)

Glycemic management during Jain fasts
por: Julka, Sandeep, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u8m3dg4i40vmhuf9oubhj63mg9